Shinilajen, which received a recommendation to halt clinical trials of the virus-based immuno-oncology drug 'Pexavac,' held an emergency briefing on the afternoon of August 4 last year at the CCMM Building in Yeouido, Seoul, to provide supplementary explanations on the futility assessment results. Moon Eun-sang, CEO of Shinilajen, is bowing his head in greeting. [Image source=Yonhap News]

Shinilajen, which received a recommendation to halt clinical trials of the virus-based immuno-oncology drug 'Pexavac,' held an emergency briefing on the afternoon of August 4 last year at the CCMM Building in Yeouido, Seoul, to provide supplementary explanations on the futility assessment results. Moon Eun-sang, CEO of Shinilajen, is bowing his head in greeting. [Image source=Yonhap News]

View original image


[Asia Economy Reporter Yoo Byung-don] The prosecution has once again conducted a search and seizure on the bio company Sillajen, which is suspected of selling stocks in advance using insider information.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing